These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 5475938)

  • 21. [Use of a parenteral estroprogestin as an inhibitor of ovulation in a single monthly administration].
    Cappello F
    Minerva Ginecol; 1975 Dec; 27(12):964-8. PubMed ID: 778680
    [No Abstract]   [Full Text] [Related]  

  • 22. [Possibilities and limitations of hormone therapy between puberty and the menopause].
    Kopera H
    Munch Med Wochenschr; 1972 Apr; 114(16):754-60. PubMed ID: 5067882
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of two regimens of a monthly injectable contraceptive containing dihydroxyprogesterone acetophenide and estradiol enanthate.
    Coutinho EM; Spinola P; Athayde C; Noronha CF; de Melo NR; Cabral ZA; Almeida JA; da Silva BL; Neto JS; Rumi DO
    Contraception; 2006 Mar; 73(3):249-52. PubMed ID: 16472564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphological study of the human ovary and mammary gland under the long-term effect of progestational agents.
    Zañartu J; Pupkin M; Rosenberg D; Dabancens A; Mendez G; Rodriguez Bravo R; Guerrero R
    Acta Eur Fertil; 1973 Dec; 4(4):187-201. PubMed ID: 4137069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Theoretic principles of hormonal contraception].
    Hammerstein J
    Med Klin; 1970 Jul; 65(27):1279-89. PubMed ID: 4931202
    [No Abstract]   [Full Text] [Related]  

  • 26. Fertility control in women with a progestogen released in microquantities from subcutaneous capsules.
    Croxatto H; Díaz S; Vera R; Etchart M; Atria P
    Am J Obstet Gynecol; 1969 Dec; 105(7):1135-8. PubMed ID: 5352594
    [No Abstract]   [Full Text] [Related]  

  • 27. Acceptability of long-term contraceptive steroid administration in humans by subcutaneous Silastic capsules.
    Tatum HJ; Coutinho EM; Filho JA; Sant'anna AR
    Am J Obstet Gynecol; 1969 Dec; 105(7):1139-43. PubMed ID: 5352595
    [No Abstract]   [Full Text] [Related]  

  • 28. [Response of peripheral receptors to the parenteral administration of an association of dihydroxyprogesterone acetophenide and estradiol-3 benzoate-17-n-butyrate. Preliminary note].
    Selvaggi L; Putignano G
    Minerva Ginecol; 1975 Dec; 27(12):961-3. PubMed ID: 778679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical trial of intramuscular injection as contraceptive compound.
    Lay CL
    Med Gynaecol Sociol; 1970; 5():7-9. PubMed ID: 12305458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enzymatic characteristics of the monkey endometrium during ovulatory and anovulatory cycles and under hormonal contraception treatment.
    Wan LS; Hilf R; Shah M; Lerner LJ; Balin H
    J Reprod Med; 1970 Apr; 4(4):43-52. PubMed ID: 4999542
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of anovulatory drugs on the human urinary tract and urinary tract infections.
    Corriere JN; Wallach EE; Murphy JJ; Garcia CR
    Obstet Gynecol; 1970 Feb; 35(2):211-6. PubMed ID: 5414207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Contraceptive indications at low dosage].
    Pinotti JA; Lane E; Jorge Jde P; Negrào PA; de Oliveira GN
    Hospital (Rio J); 1970; 78(5):1359-65. PubMed ID: 5314885
    [No Abstract]   [Full Text] [Related]  

  • 33. Vaginal bleeding patterns in users of Perlutal, a once-a-month injectable contraceptive consisting of 10 mg estradiol enanthate combined with 150 mg dihydroxyprogesterone acetophenide. A trial of 5462 woman-months.
    Martínez GH; Castañeda A; Correa JE
    Contraception; 1998 Jul; 58(1):21-7. PubMed ID: 9743892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Contraception by implantation of estradiol pellets].
    Emperaire JC; Greenblatt RB
    Gynecol Prat; 1969; 20(5):327-35. PubMed ID: 5401913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synchronization of estrus in cattle with an oral progestational agent and an injection of an estrogen.
    Wiltbank JN; Kasson CW
    J Anim Sci; 1968 Jan; 27(1):113-6. PubMed ID: 5688959
    [No Abstract]   [Full Text] [Related]  

  • 36. Artificial menstrual cycles induced in ovulating women by monthly injection of progestogen-estrogen.
    Reifenstein EC; Pratt TE; Hartzell KA; Shafer WB
    Fertil Steril; 1965; 16(5):652-62. PubMed ID: 5833973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A ten year clinical investigation of injectable contraceptives].
    Rustrian A
    Invest Med Int; 1980 Mar; 7(1):27-31. PubMed ID: 12262411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monthly injectable steroid contraceptives and cervical carcinoma.
    Thomas DB; Molina R; Rodriguez Cuevas H; Ray RM; Riotton G; Dabancens A; Benavides S; Martinez L; Salas O; Pallet JA
    Am J Epidemiol; 1989 Aug; 130(2):237-47. PubMed ID: 2665476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Medroxyprogesterone acetate administered intramuscularly every third month as a contraceptive. An investigation of the efficacy, side effects and acceptability].
    Marker IL
    Ugeskr Laeger; 1973 Feb; 135(6):294-7. PubMed ID: 4690434
    [No Abstract]   [Full Text] [Related]  

  • 40. Hormonal contraception: recent advances and controversies.
    Practice Committee of American Society for Reproductive Medicine
    Fertil Steril; 2008 Nov; 90(5 Suppl):S103-13. PubMed ID: 19007605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.